CAAS Capital Management’s Teladoc Health TDOC Stock Holding History

CAAS Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,100	Closed	-$656K	–	1024
2022 Q1	$656K	Buy	9,100 +2,300	+34%	+$166K	0.03%	364
2021 Q4	$624K	Buy	6,800 +3,600	+113%	+$430K	0.02%	509
2021 Q3	$406K	Sell	3,200 -84,000	-96%	-$12.2M	0.01%	661
2021 Q2	$14.5M	Sell	87,200 -40,300	-32%	-$6.53M	0.24%	95
2021 Q1	$23.2M	Buy	127,500 +28,800	+29%	+$6.68M	0.25%	81
2020 Q4	$19.7M	Buy	98,700 +97,500	+8,125%	+$19.8M	0.19%	115
2020 Q3	$263K	Sell	1,200 -33,700	-97%	-$7.14M	0.01%	422
2020 Q2	$6.66M	Buy	34,900 +23,800	+214%	+$4.17M	0.22%	107
2020 Q1	$1.72M	Buy	+11,100	New	+$1.29M	0.18%	103

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

CAAS Capital Management's TDOC Position: Q1 2022 in Review

CAAS Capital Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,288 shares — an estimated $165K sold.

CAAS Capital Management first reported a position in TDOC in Q4 2020 and held it in 5 quarters. The position peaked at $11.6M in Q1 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

CAAS Capital Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
CAAS Capital Management sold 2,288 Teladoc Health shares in Q1 2022, an estimated $165K.
CAAS Capital Management first reported a position in Teladoc Health in Q4 2020 and held it in 5 quarters.
CAAS Capital Management's Teladoc Health position peaked at $11.6M in Q1 2021.
680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.